Neuren Pharmaceuticals Ltd Cash Flow-to-Debt Ratio
Neuren Pharmaceuticals Ltd cash flow-to-debt ratio. Neuren Pharmaceuticals Ltd (NEU) has a Cash Flow-to-Debt Ratio of 16.08x as of June 2025, meaning its operating cash flow of AU$128.31 Million could theoretically repay 16% of its total liabilities (AU$7.98 Million) in one year. Check cash flow quality index of Neuren Pharmaceuticals Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Neuren Pharmaceuticals Ltd (2002–2024)
Cash flow-to-debt ratio of Neuren Pharmaceuticals Ltd from 2002 to 2024. Historical debt coverage capacity for Neuren Pharmaceuticals Ltd across 23 annual periods. Check how aggressively does Neuren Pharmaceuticals Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Neuren Pharmaceuticals Ltd Cash Flow-to-Debt Ratio by Year (2002–2024)
Neuren Pharmaceuticals Ltd cash flow-to-debt ratio by year from 2002 to 2024. Year-by-year debt coverage analysis for Neuren Pharmaceuticals Ltd. For the full cash flow conversion analysis, see Neuren Pharmaceuticals Ltd (NEU) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.25x | AU$-11.27 Million | AU$45.80 Million | ▼ -105.7% |
| 2023 | 4.32x | AU$184.93 Million | AU$42.76 Million | ▲ +101.6% |
| 2022 | 2.14x | AU$3.60 Million | AU$1.68 Million | ▲ +117.3% |
| 2021 | -12.42x | AU$-9.97 Million | AU$803.00K | ▼ -15.7% |
| 2020 | -10.73x | AU$-8.08 Million | AU$753.00K | ▲ +48.8% |
| 2019 | -20.96x | AU$-11.72 Million | AU$559.00K | ▼ -745.5% |
| 2018 | 3.25x | AU$6.41 Million | AU$1.97 Million | ▲ +191.8% |
| 2017 | -3.54x | AU$-5.59 Million | AU$1.58 Million | ▲ +42.1% |
| 2016 | -6.11x | AU$-12.38 Million | AU$2.03 Million | ▼ -20.0% |
| 2015 | -5.09x | AU$-12.73 Million | AU$2.50 Million | ▼ -140.4% |
| 2014 | -2.12x | AU$-6.41 Million | AU$3.03 Million | ▲ +43.5% |
| 2013 | -3.75x | AU$-7.71 Million | AU$2.06 Million | ▼ -172.0% |
| 2012 | -1.38x | AU$-2.95 Million | AU$2.14 Million | ▲ +25.9% |
| 2011 | -1.86x | AU$-3.13 Million | AU$1.68 Million | ▼ -41.2% |
| 2010 | -1.32x | AU$-2.87 Million | AU$2.18 Million | ▼ -200.3% |
| 2009 | -0.44x | AU$-1.29 Million | AU$2.94 Million | ▲ +85.6% |
| 2008 | -3.04x | AU$-9.04 Million | AU$2.97 Million | ▼ -86.1% |
| 2007 | -1.63x | AU$-11.50 Million | AU$7.04 Million | ▲ +39.6% |
| 2006 | -2.71x | AU$-9.14 Million | AU$3.38 Million | ▲ +1.8% |
| 2005 | -2.76x | AU$-8.39 Million | AU$3.05 Million | ▼ -214.3% |
| 2004 | -0.88x | AU$-3.68 Million | AU$4.20 Million | ▼ -188.8% |
| 2003 | -0.30x | AU$-4.68 Million | AU$15.41 Million | ▲ +91.2% |
| 2002 | -3.44x | AU$-5.19 Million | AU$1.51 Million | — |